GeneMedRx Software
Cellular Genetix is pleased to offer GeneMedRx for the medical professional. Now you can add another dimension to providing safer and more efficacious care to your patients by ordering DNA Drug Reaction Profiles for them. We can provide you with a simple collection kit and return samples to our affiliated laboratory.
Order a one year subscription
for $199.00 or call 215-665-1193 for more information.
 GeneMedRx is a software tool designed to help physicians predict whether or not drugs are safe and effective for patients. This prediction is based both on the potential interaction of drug combinations (drug-drug) and the genetic ability of the patient to process drugs.
GeneMedRx is the upgraded, pharmacogenetics-ready version of Mental Health Connections P450 Interactions program. The most extensive coverage of cytochrome P450s available and in use by physicians since 1997.
View a Demo.
Constantly updated to keep pace with the dozens of relevant reports appearing each month. The database currently contains:
- 2000 Drugs and Metabolites
- 4500 PubMed Links
- 2000 Unique Notes
- 1500 Substrates
- 1000 Inhibitors and Inducers
Unlike other DDI programs GeneMedRx uses an algorithm to predict and weight DDIs for drug combinations not reported in the literature.
- Available from any computer with Internet access.
- Colors and icons highlight interactions of concern.
- Optional entry of patient's genetic profile recommends dose changes based on drug-gene interactions.
- Program allows for what-if scenarios.
- A clinical confidence rating is given for each prediction.
- Not unduly alarmist.
- Results are presented in a simple form with detailed notes and references readily available.
1. Input patient prescription, OTC, and herbal medicine regimens, food intakes and chemical exposures. If available, input patient's pharmacogenetic test results.
2. Scan the results for potential DDIs based on the metabolism of the drugs in questions. Does not include the minority of DDIs for which metabolism is not understood.
3. Predict the results of changes in prescribing by seeing the results of adding or removing a particular drug.
4. If needed, pick a new drug or dosage based on the predicted safety profile.
Jessica R. Oesterheld, M.D., a practicing psychiatrist and educator, is a frequent author and lecturer on metabolism-based pharmacology in adults and children. Her interest arose from clinical experiences with adverse drug reactions caused by CYP based drug interactions.
Neil B. Sandson, M.D., is Director of the Division of Education and Residency Training at Sheppard Pratt Health System.
David N. Osser, M.D., is a clinical psychopharmacology consultant and a member of the International Psychopharmacology Algorithm Project.
|
–